Dr. Jasnit Makkar, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $14,563 | 8 | 91.8% |
| Food and Beverage | $859.59 | 6 | 5.4% |
| Unspecified | $447.50 | 1 | 2.8% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Siemens Medical Solutions USA, Inc. | $4,340 | 2 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $3,773 | 4 | $0 (2021) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $3,750 | 1 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $2,700 | 1 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $691.55 | 3 | $0 (2024) |
| ABBVIE INC. | $250.00 | 2 | $0 (2024) |
| FUJIFILM Healthcare Americas Corporation | $201.94 | 1 | $0 (2024) |
| Boston Scientific Corporation | $163.60 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $774.44 | 3 | E.R. Squibb & Sons, L.L.C. ($447.50) |
| 2023 | $2,989 | 3 | Otsuka America Pharmaceutical, Inc. ($2,700) |
| 2022 | $5,750 | 2 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($3,750) |
| 2021 | $6,113 | 5 | Merck Sharp & Dohme Corporation ($3,773) |
| 2019 | $119.05 | 1 | E.R. Squibb & Sons, L.L.C. ($119.05) |
| 2018 | $125.00 | 1 | E.R. Squibb & Sons, L.L.C. ($125.00) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/08/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | — | Cash or cash equivalent | $447.50 | Research |
| Study: PhII Nivo vs. Nivo+Rela IO nave 2L+ HCC - A Phase 2, Randomized, Open-label Study of Relatlimab in Combination with Nivolumab in Participants with Advanced Hepatocellular Carcinoma who are Naive to IO Therapy but Progressed on Tyrosine Kinase Inhibitors • Category: Oncology | ||||||
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | FUJIFILM Healthcare Americas Corporation | SYNAPSE 3D (Device) | Food and Beverage | In-kind items and services | $201.94 | General |
| Category: Medical Device | ||||||
| 12/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Consulting Fee | Cash or cash equivalent | $2,700.00 | General |
| Category: NEPHROLOGY | ||||||
| 03/31/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $163.60 | General |
| Category: General - Therapies_IC | ||||||
| 09/07/2022 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| 05/04/2022 | Siemens Medical Solutions USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 12/07/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $1,290.00 | General |
| Category: ONCOLOGY | ||||||
| 11/17/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $175.00 | General |
| Category: ONCOLOGY | ||||||
| 08/18/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $2,220.00 | General |
| Category: ONCOLOGY | ||||||
| 08/02/2021 | Siemens Medical Solutions USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,340.00 | General |
| 07/20/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $87.50 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $119.05 | General |
| Category: Oncology | ||||||
| 01/16/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PhII Nivo vs. Nivo+Rela IO nave 2L+ HCC - A Phase 2, Randomized, Open-label Study of Relatlimab in Combination with Nivolumab in Participants with Advanced Hepatocellular Carcinoma who are Naive to IO Therapy but Progressed on Tyrosine Kinase Inhibitors | E.R. Squibb & Sons, L.L.C. | $447.50 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 3,309 | 9,649 | $1.0M | $109,454 |
| 2022 | 29 | 3,122 | 8,946 | $985,258 | $111,774 |
| 2021 | 30 | 2,945 | 7,811 | $895,441 | $120,516 |
| 2020 | 25 | 3,130 | 10,766 | $882,540 | $117,832 |
All Medicare Procedures & Services
152 procedure records from CMS Medicare Utilization — Page 2 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 71046 | X-ray of chest, 2 views | Office | 2023 | 27 | 29 | $18,610 | $866.92 | 4.7% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2023 | 12 | 12 | $5,160 | $835.85 | 16.2% |
| 74220 | Single contrast x-ray of esophagus | Facility | 2023 | 28 | 29 | $3,190 | $739.20 | 23.2% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Facility | 2023 | 12 | 13 | $5,330 | $660.63 | 12.4% |
| 76536 | Ultrasound scan of head and neck soft tissue | Facility | 2023 | 17 | 17 | $4,590 | $411.01 | 9.0% |
| 74221 | Double contrast x-ray of esophagus | Facility | 2023 | 13 | 13 | $2,600 | $393.84 | 15.1% |
| 76000 | Imaging guidance for procedure, 60 minutes or less | Facility | 2023 | 26 | 27 | $1,890 | $392.59 | 20.8% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Facility | 2023 | 11 | 12 | $3,240 | $304.30 | 9.4% |
| 93926 | Ultrasound of one leg arteries or artery grafts | Facility | 2023 | 11 | 12 | $1,800 | $248.40 | 13.8% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 37 | 2,191 | $21,910 | $248.12 | 1.1% |
| 76857 | Limited ultrasound scan of pelvis | Facility | 2023 | 11 | 11 | $3,300 | $233.56 | 7.1% |
| 74019 | X-ray of abdomen, 2 views | Facility | 2023 | 22 | 22 | $1,320 | $222.48 | 16.9% |
| 73130 | X-ray of hand, minimum of 3 views | Facility | 2023 | 11 | 14 | $560.00 | $98.66 | 17.6% |
| 73030 | X-ray of shoulder, minimum of 2 views | Facility | 2023 | 11 | 11 | $550.00 | $82.92 | 15.1% |
| 71045 | X-ray of chest, 1 view | Facility | 2022 | 1,144 | 1,842 | $92,070 | $14,581 | 15.8% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Facility | 2022 | 166 | 170 | $69,700 | $12,690 | 18.2% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2022 | 35 | 35 | $75,250 | $10,670 | 14.2% |
| 74183 | Mri scan of abdomen before and after contrast | Office | 2022 | 23 | 24 | $83,060 | $8,343 | 10.0% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Facility | 2022 | 97 | 98 | $38,220 | $7,142 | 18.7% |
| 72197 | Mri scan of pelvis before and after contrast | Office | 2022 | 22 | 23 | $88,910 | $6,613 | 7.4% |
| 74183 | Mri scan of abdomen before and after contrast | Facility | 2022 | 63 | 63 | $34,650 | $5,518 | 15.9% |
| 71250 | Ct scan of chest without contrast | Facility | 2022 | 120 | 121 | $82,940 | $5,409 | 6.5% |
| 71260 | Ct scan of chest with contrast | Facility | 2022 | 82 | 82 | $64,960 | $3,789 | 5.8% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Facility | 2022 | 104 | 107 | $37,450 | $3,343 | 8.9% |
| 71046 | X-ray of chest, 2 views | Facility | 2022 | 313 | 331 | $16,550 | $3,022 | 18.3% |
About Dr. Jasnit Makkar, M.D
Dr. Jasnit Makkar, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Valhalla, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2010. The National Provider Identifier (NPI) number assigned to this provider is 1811213358.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jasnit Makkar, M.D has received a total of $15,870 in payments from pharmaceutical and medical device companies, with $774.44 received in 2024. These payments were reported across 15 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($14,563).
As a Medicare-enrolled provider, Makkar has provided services to 12,506 Medicare beneficiaries, totaling 37,172 services with total Medicare billing of $459,575. Data is available for 4 years (2020–2023), covering 152 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Diagnostic Radiology
- Location Valhalla, NY
- Active Since 04/08/2010
- Last Updated 09/28/2015
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811213358
Products in Payments
- KEYTRUDA (Biological) $3,773
- JYNARQUE (Drug) $2,700
- OPDUALAG (Drug) $447.50
- VRAYLAR (Drug) $250.00
- OPDIVO (Biological) $244.05
- SYNAPSE 3D (Device) $201.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Valhalla
Eitan Glucksman, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $30,301
Dr. Tasleem Katchi, M.b.b.s, M.B.B.S
Student in an Organized Health Care Education/Training Program — Payments: $7,795
Dr. Logan Carr, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $6,431
Dr. Gabriel Froula, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $4,560
Dr. Ethan Paulin, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $4,429
Jordan Stumph, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $3,842